6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: NeuroSense Therapeutics Ltd.
Filed: March 27, 2025
Period of Report: March 27, 2025
Accession Number: 0001013762-25-002993

View Document ↗ View on SEC.gov ↗